NFL Hall of Famer Brett Favre was recently diagnosed with Parkinson’s disease. The 54-year-old shared the news on Tuesday ...

US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects ...

Patients with Parkinson’s disease (PD) suffer from a variety of movement disorders caused by a breakdown of brain neurons.

A significant breakthrough in the understanding of sleep mechanism opens new promise for treating sleep disorders and associated neuropsychiatric conditions: Scientists have pinpointed the melatonin ...

Beginning in 2017, nearly 2,000 former NFL players participated in a study that sought to explore sensitive, personal terrain: determining how many believed that they had developed a neurodegenerative ...

A significant breakthrough in the understanding of sleep mechanism opens new promise for treating sleep disorders and associated neuropsychiatric conditions: Scientists have pinpointed the melatonin ...

Scientists have identified the melatonin MT1 receptor as a key regulator of REM sleep, crucial for memory, dreaming, and ...

With fresh, positive data in hand, Biohaven now believes its medicine could be the first to receive FDA approval for spinocerebellar ataxia.

Parkinson's comes on slowly, and diagnosing the often-devastating movement disorder, particularly in its early stages, ...

Johns Hopkins launches OneNeuro, a cross-disciplinary initiative to utilize emerging technologies and AI to finally crack the code on the enigmatic human brain ...

There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing ...

There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing ...